Integrin beta 1/CD29 RNAi Summary
Homo sapiens integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) (ITGB1), transcript variant 1A, mRNA
Packaging, Storage & Formulations
Aliquot and store at -20C or -80C. Avoid freeze-thaw cycles.
This product is supplied by Abnova. There is also a 10 nmol size available for $ 255 This product is produced by and distributed for Abnova, a company based in Taiwan.
Alternate Names for Integrin beta 1/CD29 RNAi
- CD29 antigen
- Fibronectin receptor subunit beta
- integrin beta-1
- integrin VLA-4 beta subunit
- integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includesMDF2, MSK12)
- very late activation protein, beta polypeptide
- VLA-4 subunit beta
Position of the Chimera RNAi. The related RNAi products listed were designed from different accesion number but sharing the same RNAi sequence. Chimera RNA interference (chimera RNAi) is process by which small interfering RNA/DNA chimera triggers the destruction of mRNA for the original gene. The discovery work, design, and application of chimera RNAi has been pioneered by Professor Kaoru Saigo and Dr. Kumiko Ui-Tei at the University of Tokyo. Chimera RNAi has many advantages over the conventional siRNAs. First, it has been demonstrated to have reliable knock-down for over 10,000 human genes. Because the human genome is composed of an intricate, genetic network, chimera RNAi's unique design has successfully obviated the off-target effects including microRNA-based influence. Another advantage of the chimera RNAi technology is its effectiveness at low concentrations (0.5nM to 5nM); only mRNA is destroyed so genomic genes are not affected. Finally, having both the sense and anti-sense strands consisting RNA/DNA chimera, it offers much greater compound stability for streamlining in vitro and in vivo assays and applications while minimizing interferon induction and other adverse reactions.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. RNAi are guaranteed
for 3 months from date of receipt.
Customers Who Viewed This Item Also Viewed...
Applications: WB, ICC/IF, IHC, IHC-P
Species: Hu, Mu
Applications: WB, ICC/IF, IHC, IHC-P, IP
Species: Hu, Mu, Rb(-)
Applications: WB, ELISA, Flow, ICC/IF, IHC, IHC-P
Applications: WB, Flow, Func, ICC/IF, IHC, IHC-Fr, IHC-P, IP, In vivo
Species: Hu, Mu, Rt
Applications: WB, ELISA, ICC/IF
Species: Hu, Ca, GP
Applications: Flow, ICC/IF, IHC, IHC-Fr, IP
Applications: WB, ELISA, Flow, ICC/IF, IHC, IHC-Fr, IHC-P, IP
Applications: WB, Flow, IHC
Applications: WB, Flow
Species: Hu, Rt, Ca, Mk
Applications: WB, IHC, IHC-P, IP
Species: Hu, Mu, Rt, Ca, Rb
Applications: WB, Simple Western, ICC/IF, IHC, IHC-P
Species: Hu, Po, Ca
Applications: WB, Flow, IHC, ICC
Species: Hu, Mu, Rt
Applications: WB, Simple Western, Flow, ICC/IF, IHC, IHC-Fr, IHC-P
Publications for Integrin beta 1/CD29 RNAi (H00003688-R07)(1)
Showing Publication 1 - 1
Reviews for Integrin beta 1/CD29 RNAi (H00003688-R07) (0)
There are no reviews for Integrin beta 1/CD29 RNAi (H00003688-R07).
By submitting a review earn points towards our Rewards Program.
- 250 points for product review
- 500 additional points for an image with your product review
- Double points (500) if you are the first to review this product
- Double points (1000) if you are the first to review this product with an image
Additional Integrin beta 1/CD29 RNAi Products
Related Products by Gene
Bioinformatics Tool for Integrin beta 1/CD29 RNAi (H00003688-R07)
Discover related pathways, diseases and genes to Integrin beta 1/CD29 RNAi (H00003688-R07). Need help?
Read the Bioinformatics Tool Guide
for instructions on using this tool.
Blogs on Integrin beta 1/CD29.